Current Report Filing (8-k)
June 28 2022 - 02:41PM
Edgar (US Regulatory)
0001809353 false 0001809353 2022-06-28
2022-06-28 0001809353
HPXU:ClassOrdinarySharesParValue0.0001PerShareMember 2022-06-28
2022-06-28 0001809353
HPXU:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOfDollar11.50Member
2022-06-28 2022-06-28 0001809353
HPXU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember
2022-06-28 2022-06-28 iso4217:USD xbrli:shares iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 28, 2022
HPX CORP.
(Exact Name of Registrant as Specified in its Charter)
Cayman Islands |
|
001-39382 |
|
98-1550444 |
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
1000 N. West Street, Suite 1200
Wilmington,
DE
|
|
19801 |
(Address of Principal Executive
Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (302)
295-4929
Not Applicable
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
¨ |
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each
class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Class A ordinary shares, par value $0.0001 per
share |
|
HPX |
|
New York Stock Exchange |
Redeemable warrants, each whole warrant exercisable for one Class A
ordinary share at an exercise price of
$11.50 |
|
HPX.WS |
|
New York Stock Exchange |
Units, each consisting of one Class A ordinary share and one-half
of one redeemable warrant |
|
HPX.U |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.03 Creation of a Direct Financial Obligation or an
Obligation under an Off-Balance Sheet Arrangement of a
Registrant
The information relating to the Note included in Item 8.01 is
incorporated by reference in this item to the extent required
herein.
Item 8.01 Other Events.
On June 24, 2022, HPX Capital Partners LLC (the “Sponsor”) loaned
to HPX Corp. (the “Company”) an aggregate of $700,000 for working
capital purposes. The loan is evidenced by a promissory note (the
“Note”) which is non-interest bearing and payable upon the
consummation by the Company of a merger, share exchange, asset
acquisition, or other similar business combination with one or more
businesses or entities (a “Business Combination”).
If the Company does not consummate a Business Combination, the Note
will not be repaid and all amounts owed under the Note will be
forgiven except to the extent that the Company has funds available
to it outside of its trust account established in connection with
the initial public offering. The issuance of the Note was exempt
pursuant to Section 4(a)(2) of the Securities Act of 1933, as
amended.
The foregoing summary of the Note is qualified in its entirety by
reference to the text of the Note, which is filed as an exhibit
hereto and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly
authorized.
Date: June 28, 2022
|
HPX CORP. |
|
|
|
|
By: |
/s/ Carlos Piani |
|
|
Carlos Piani |
|
|
Chief Executive Officer and Chief
Financial Officer |
HPX (NYSE:HPX)
Historical Stock Chart
From Dec 2022 to Jan 2023
HPX (NYSE:HPX)
Historical Stock Chart
From Jan 2022 to Jan 2023